GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
AI-Designed Oral GLP-1RA Shows Promise in Weight Loss
In the ongoing global health challenge of obesity and its associated conditions, the search for effective and convenient treatments is paramount. Recently, a significant breakthrough has emerged from China-based MindRank, a biotech company that has reported promising results from its Phase IIb clinical trial for an oral medication known as MDR-001.